chr3-11028856-GC-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003042.4(SLC6A1):c.1191+17delC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0782 in 1,570,694 control chromosomes in the GnomAD database, including 13,253 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 4554 hom., cov: 29)
Exomes 𝑓: 0.068 ( 8699 hom. )
Consequence
SLC6A1
NM_003042.4 intron
NM_003042.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.92
Genes affected
SLC6A1 (HGNC:11042): (solute carrier family 6 member 1) The protein encoded by this gene is a gamma-aminobutyric acid (GABA) transporter that localizes to the plasma membrane. The encoded protein removes GABA from the synaptic cleft, restoring it to presynaptic terminals. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 3-11028856-GC-G is Benign according to our data. Variant chr3-11028856-GC-G is described in ClinVar as [Benign]. Clinvar id is 1166941.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.433 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A1 | NM_003042.4 | c.1191+17delC | intron_variant | Intron 11 of 15 | ENST00000287766.10 | NP_003033.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.169 AC: 25520AN: 151088Hom.: 4527 Cov.: 29
GnomAD3 genomes
AF:
AC:
25520
AN:
151088
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.113 AC: 26470AN: 234778Hom.: 3376 AF XY: 0.109 AC XY: 13861AN XY: 127144
GnomAD3 exomes
AF:
AC:
26470
AN:
234778
Hom.:
AF XY:
AC XY:
13861
AN XY:
127144
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0685 AC: 97230AN: 1419488Hom.: 8699 Cov.: 24 AF XY: 0.0699 AC XY: 49530AN XY: 708456
GnomAD4 exome
AF:
AC:
97230
AN:
1419488
Hom.:
Cov.:
24
AF XY:
AC XY:
49530
AN XY:
708456
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.169 AC: 25610AN: 151206Hom.: 4554 Cov.: 29 AF XY: 0.170 AC XY: 12526AN XY: 73838
GnomAD4 genome
AF:
AC:
25610
AN:
151206
Hom.:
Cov.:
29
AF XY:
AC XY:
12526
AN XY:
73838
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Epilepsy with myoclonic atonic seizures Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
Nov 22, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at